Janeta Popovici-Müller

4.2k citations

20 papers · 578 indexed · h-index 13

Co-authors: Stefan Größ Lenny Dang Scott A. Biller Kimberly Straley Katharine Yen Gerald W. Shipps Valeria R. Fantin Shinsan M. Su
Topics: Acute Myeloid Leukemia Research (5 papers)Cancer, Hypoxia, and Metabolism (5 papers)Glioma Diagnosis and Treatment (4 papers)
Cited by: Cancer Research Genetics Hematology
Journals: Journal of Biological Chemistry Nature Communications Blood
Partner nations: United States China India

In The Last Decade

Janeta Popovici-Müller

20 papers receiving 567 citations

Peers

Countries citing papers authored by Janeta Popovici-Müller

Since Specialization

Citations

This map shows the geographic impact of Janeta Popovici-Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janeta Popovici-Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janeta Popovici-Müller more than expected).

Fields of papers citing papers by Janeta Popovici-Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janeta Popovici-Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janeta Popovici-Müller. The network helps show where Janeta Popovici-Müller may publish in the future.

Co-authorship network of co-authors of Janeta Popovici-Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Janeta Popovici-Müller. A scholar is included among the top collaborators of Janeta Popovici-Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janeta Popovici-Müller. Janeta Popovici-Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant Malignancies 2021 ·Drug Metabolism and Disposition ·Yue Chen,N. Nagaraja,Bin Fan,Luke Utley,René M. Lemieux,Janeta Popovici-Müller,Lenny Dang,Hyeryun Kim,Liping Yan,Shinsan M. Su,Scott A. Biller,Hua Yang	7
2	Preclinical toxicology profile of squalene epoxidase inhibitors 2020 ·Toxicology and Applied Pharmacology ·Raj Nagaraja,Andrew Olaharski,Rohini Narayanaswamy,Christopher E. Mahoney,David Pirman,Stefan Größ,Thomas P. Roddy,Janeta Popovici-Müller,Gromoslaw A. Smolen,Lee Silverman	17
3	Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase 2019 ·Nature Communications ·Anil K. Padyana,Stefan Größ,Lei Jin,Giovanni Cianchetta,Rohini Narayanaswamy,Feng Wang,Rui Wang,Fang Cheng,Xiaobing Lv,Scott A. Biller,Lenny Dang,Christopher E. Mahoney,N. Nagaraja,David Pirman,Zhihua Sui,Janeta Popovici-Müller,Gromoslaw A. Smolen	99
4	Abstract B126: AG-881, a brain penetrant, potent, pan-mutant IDH (mIDH) inhibitor for use in mIDH solid and hematologic malignancies 2018 ·Molecular Cancer Therapeutics ·Katharine Yen,Zenon Konteatis,Zhihua Sui,Erin Artin,Lenny Dang,Kimberly Straley,Erica R. Tobin,Carl Campos,Hua Yang,Raj Nagaraja,Yue Chen,Hyeryun Kim,Camelia Gliser,Brandon Nicolay,Andrew Olaharski,Lee Silverman,Scott A. Biller,Shinsan M. Su,Ingo K. Mellinghoff,Janeta Popovici-Müller	16
5	Biochemical, Cellular, and Biophysical Characterization of a Potent Inhibitor of Mutant Isocitrate Dehydrogenase IDH1 2014 ·Journal of Biological Chemistry ·Mindy I. Davis,Stefan Größ,Min Shen,Kimberly Straley,Rajan Pragani,Wendy Lea,Janeta Popovici-Müller,Byron DeLaBarre,Erin Artin,Natasha Thorne,Douglas S. Auld,Zhuyin Li,Lenny Dang,Matthew B. Boxer,Anton Simeonov	72
6	AG-120, an Oral, Selective, First-in-Class, Potent Inhibitor of Mutant IDH1, Reduces Intracellular 2HG and Induces Cellular Differentiation in TF-1 R132H Cells and Primary Human IDH1 Mutant AML Patient Samples Treated Ex Vivo 2014 ·Blood ·Erica Hansen,Cyril Quivoron,(unknown),René M. Lemieux,Janeta Popovici-Müller,Hossein Sadrzadeh,Amir T. Fathi,Camelia Gliser,Muriel D. David,Véronique Saada,Jean‐Baptiste Micol,Olivier Bernard,Marion Dorsch,Hua Yang,Michael Su,Sam Agresta,Stéphane de Botton,Virginie Penard‐Lacronique,Katharine Yen	40
7	The identification of novel 5′-amino gemcitabine analogs as potent RRM1 inhibitors 2014 ·Bioorganic & Medicinal Chemistry ·Marc Labroli,Michael P. Dwyer,Ruichao Shen,Janeta Popovici-Müller,(unknown),Daniel F. Wyss,Mark A. McCoy,Dianah Barrett,Nicole R. Davis,Wolfgang Seghezzi,Fergus Shanahan,Lorena Taricani,Maribel Beaumont,(unknown),David Parry,Timothy J. Guzi	10
8	Abstract 1194: IDH1 mutant inhibitor induces cellular differentiation and offers a combination benefit with Ara-C in a primary human Idh1 mutant AML xenograft model 2014 ·Cancer Research ·(unknown),Yue Chen,Fang Wang,René M. Lemieux,Janeta Popovici-Müller,Hua Yang,Kimberly Straley,Sung Choe,Marion Dorsch,Sam Agresta,David P. Schenkein,Scott A. Biller,Michael Su	3
9	Modulating the interaction between CDK2 and cyclin A with a quinoline-based inhibitor 2013 ·Bioorganic & Medicinal Chemistry Letters ·Yongqi Deng,Gerald W. Shipps,Lianyun Zhao,M. Arshad Siddiqui,Janeta Popovici-Müller,(unknown),José S. Duca,Alan Hruza,Thierry Fischmann,Vincent Madison,Rumin Zhang,Charles McNemar,Todd Mayhood,Rosalinda Syto,(unknown),Paul T. Kirschmeier,Emma Lees,David Parry,William T. Windsor	17
10	IDH1 Mutant Inhibitor Induces Cellular Differentiation and Offers a Combination Benefit With Ara-C In a Primary Human Idh1 Mutant AML Xenograft Model 2013 ·Blood ·Katharine Yen,René M. Lemieux,Janeta Popovici-Müller,Yue Chen,Hua Yang,(unknown),Sung Choe,Marion Dorsch,Samuel Agresta,David P. Schenkein,Scott A. Biller,Michael Su,Fang Wang	13
11	ML309: A potent inhibitor of R132H mutant IDH1 capable of reducing 2-hydroxyglutarate production in U87 MG glioblastoma cells 2013 ·Europe PMC (PubMed Central) ·Mindy I. Davis,Rajan Pragani,Janeta Popovici-Müller,Stefan Größ,Natasha Thorne,(unknown),Valeria R. Fantin,Kimberly Straley,Michael Su,Lenny Dang,Anton Simeonov,Min Shen,Matthew B. Boxer	16
12	Syntheses of 5′-amino-2′,5′-dideoxy-2′,2′-difluorocytidine derivatives as novel anticancer nucleoside analogs 2013 ·Tetrahedron Letters ·Marc Labroli,Michael P. Dwyer,Ruichao Shen,Janeta Popovici-Müller,(unknown),(unknown),(unknown),Kamil Paruch,Timothy J. Guzi	5
13	Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo 2012 ·ACS Medicinal Chemistry Letters ·Janeta Popovici-Müller,Jeffrey O. Saunders,Francesco G. Salituro,Jeremy Travins,Shunqi Yan,Fang Zhao,Stefan Größ,Lenny Dang,Katharine Yen,Hua Yang,Kimberly Straley,Shengfang Jin,Kaiko Kunii,Valeria R. Fantin,Shunan Zhang,(unknown),(unknown),Scott A. Biller,Shinsan M. Su	160
14	Bridged aromatic alkenes for the study of carbocation–π interaction 2010 ·Tetrahedron ·Thomas A. Spencer,Janeta Popovici-Müller,(unknown),(unknown),(unknown),Jessica M. Sin,R. Ditchfield	9
15	Discovery of 4H-pyrazolo[1,5-a]pyrimidin-7-ones as potent inhibitors of hepatitis C virus polymerase 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yongqi Deng,Gerald W. Shipps,Tong Wang,Janeta Popovici-Müller,K Rösner,M. Arshad Siddiqui,José S. Duca,Alan Cooper,Michael Cable	12
16	Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase 2009 ·Bioorganic & Medicinal Chemistry Letters ·Janeta Popovici-Müller,Gerald W. Shipps,K Rösner,Yongqi Deng,Tong Wang,(unknown),Meredith A. Brown,M. Arshad Siddiqui,Alan Cooper,José S. Duca,Michael Cable,Viyyoor Girijavallabhan	22
17	Method for Quantitative Protein−Ligand Affinity Measurements in Compound Mixtures 2007 ·Analytical Chemistry ·D. Allen Annis,Gerald W. Shipps,Yongqi Deng,Janeta Popovici-Müller,M. Arshad Siddiqui,(unknown),(unknown),William T. Windsor	37
18	Preparation and biochemical evaluation of fluorenone-containing lipid analogs 2006 ·Bioorganic & Medicinal Chemistry Letters ·Thomas A. Spencer,(unknown),Janeta Popovici-Müller,Ithan D. Peltan,Phoebe E. Fielding,Christopher J. Fielding	6
19	Aminothiazole inhibitors of HCV RNA polymerase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gerald W. Shipps,Yongqi Deng,Tong Wang,Janeta Popovici-Müller,(unknown),K Rösner,Alan Cooper,Viyyoor Girijavallabhan,Nancy Butkiewicz,Michael Cable	12
20	The singular reduction of 1,8-bis-hydroxymethylnaphthalene to a benzonorcaradiene by LiAlH4 1997 ·Tetrahedron Letters ·Janeta Popovici-Müller,Thomas A. Spencer	5

About Janeta Popovici-Müller

Janeta Popovici-Müller is a scholar working on Cancer Research, Hematology and Hepatology, having authored 20 papers that have together received 578 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Glioma Diagnosis and Treatment (4 papers). The work is most often cited by research in Cancer Research (208 citations), Genetics (129 citations) and Hematology (71 citations). Janeta Popovici-Müller has collaborated with scholars based in United States, China and India. Frequent co-authors include Stefan Größ, Lenny Dang, Scott A. Biller, Kimberly Straley, Katharine Yen, Gerald W. Shipps, Valeria R. Fantin, Shinsan M. Su, Yongqi Deng and Hua Yang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact